sprite-preloader
Donnerstag, 24.04.2014 Börsentäglich über 12.000 News von 475 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Passende Knock-Outs zu Ihrer Suchanfrage (Anzeige)
Erweiterte
Suche
lynx
Ad hoc-Mitteilungen

WKN: 899527 ISIN: US0153511094 Ticker-Symbol: AXP 
Aktie:
Branche
Pharma
Aktienmarkt
NASDAQ-100
S&P 500
NASDAQ Biotech
1-Jahres-Chart
ALEXION PHARMACEUTICALS INC Chart 1 Jahr
1-Woche-Intraday-Chart
ALEXION PHARMACEUTICALS INC 1-Woche-Intraday-Chart
RealtimeGeldBriefZeit
112,70
112,97
22:00

Aktuelle News zu ALEXION PHARMACEUTICALS Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache:
LeserMedien
ALEXION PHARMACEUTICALS Aktie jetzt ab 5 Dollar handeln!

--> Artikel lesen
23:07Gilead, Alexion, Biogen, Or Celgene: 1 Mindboggling Metric Identifies The Best Value!-

--> Artikel lesen
22:13Alexion Posts Strong Earnings in Q1-

--> Artikel lesen
20:52Alexion Pharmaceuticals: How to Buck a Biotech Selloff2

--> Artikel lesen
16:43UPDATE 1-Alexion Pharma raises 2014 profit forecast again3

--> Artikel lesen
15:35Today's Top Health Care Stocks to Watch: AstraZeneca plc, Alexion Pharmaceuticals, Celgene Corporati8

--> Artikel lesen
14:55Alexion Pharma raises 2014 profit forecast on strong Soliris sales6

--> Artikel lesen
13:09Alexion Q1 Profit Up; Lifts Adj. EPS View, Backs Revenue Outlook For FY146
WASHINGTON (dpa-AFX) - Biopharmaceutical company Alexion Pharmaceuticals, Inc.'s (ALXN) profit for the first quarter rose to $159.4 million or $0.79 per share from last year's $82.2 million...
--> Artikel lesen
12:31Alexion Pharmaceuticals, Inc. Initiates Soliris Safety, Efficacy Trial2

--> Artikel lesen
MiEarnings Release Schedule -- Research on Coca-Cola Enterprises, Alexion Pharma, DuPont Fabros Technology, and Sigma-Aldrich4
LONDON, April 23, 2014 /PRNewswire/ -- Earningsource.com provides investors with earnings schedule updates throughout the earnings season. With timely information on past earnings performance and...
--> Artikel lesen
MiAlliance Fiber Optic, Talisman Energy, Gilead Sciences, Biogen Idec and Alexion Pharmaceuticals highlighted as Zacks Bull and Bear of the Day8
CHICAGO, April 23, 2014 /PRNewswire/ -- Zacks Equity Research highlights Alliance Fiber Optic (Nasdaq:AFOP-Free Report) as the Bull of the Day and Talisman Energy (NYSE:TLM-Free...
--> Artikel lesen
MiAppointments, Network Agreements, Earnings Results Schedules, and Legal Claims - Analyst Notes on Alexion, Humana, Eli Lilly, Teva and Cigna6
NEW YORK, April 23, 2014 /PRNewswire/ -- Today, Analysts Review released its analysts' notes regarding Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN), Humana Inc. (NYSE: HUM), Eli Lilly & Co. (NYSE:...
--> Artikel lesen
MiAlexion: EC Orphan Drug Status For Soliris In Prevention Of Graft Rejection4
WASHINGTON (dpa-AFX) - Alexion Pharmaceuticals, Inc. (ALXN) Wednesday said the European Commission has granted an orphan drug designation or ODD to Soliris (eculizumab), a first-in-class terminal...
--> Artikel lesen
MiAlexion Pharmaceuticals, Inc. Receives Orphan Drug Designation from EC for Soliris2

--> Artikel lesen
DiAlexion Likely to Keep Earnings Streak Alive7

--> Artikel lesen
DiNew Data from Studies, Enrollment in Registry, Upcoming Conferences, and Stock Price Movement - Analyst Notes on Alexion, Boston Scientific, Thermo Fisher Scientific, Valeant, and Jazz Pharmaceuticals3
NEW YORK, April 22, 2014 /PRNewswire/ -- Today, Analysts Review released its analysts' notes regarding Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), Boston Scientific Corporation (NYSE:BSX), Thermo...
--> Artikel lesen
DiHere's What You Need to Know About Alexion Pharmaceuticals' Upcoming Earnings6

--> Artikel lesen
MoIs a Surprise Coming for Alexion Pharmaceuticals (ALXN) This Earnings Season? - Tale of the Tape3

--> Artikel lesen
17.04.ALEXION PHARMACEUTICALS INC - 8-K, Current Report5

--> Artikel lesen
17.04.Look for Shares of Alexion Pharmaceuticals to Potentially Pullback after Yesterday's 2.50% Rise1

--> Artikel lesen
16.04.Alexion Pharmaceuticals Bullish Moving Average Crossover Alert1

--> Artikel lesen
Seite:  Weiter >>
224 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten:
VerkaufenHaltenKaufen
ALEXION PHARMACEUTICALS INC-Investoren interessieren sich auch für diese News

Unternehmen / AktienAktienkurs%Top-Nachrichten
GILEAD SCIENCES52,94-2,29 %Gilead Sciences-Aktie: Quartalszahlen dank Solvadi au
San Francisco - Gilead Sciences-Aktienanalyse von Analyst Brian Abrahams von Wells Fargo Advisors: Der Aktienanalyst Brian Abrahams von Wells Fargo Advisors stuft die Aktien des US-Biotechkonzerns Gilead...
--> Artikel lesen
NOVO NORDISK32,50-0,02 %NASDAQ OMX Copenhagen A/S: Novo Nordisk A/S - reduction in share capital by the cancellation of treasury shares
The share capital of the following share will be reduced in NASDAQ OMX systems as per 25 April 2014 due to the cancellation of treasury shares. ISIN: DK0060534915 ...
--> Artikel lesen
CELGENE101,18-4,55 %Celgene Q1 Adj. Profit Tops View, Backs 2014 View
SUMMIT (dpa-AFX) - Drug maker Celgene Corp. (CELG) reported first-quarter net income of $279.7 million or $0.66 per share, down from $384.9 million or $0.89 per share in the prior-year quarter.Adjusted...
--> Artikel lesen
STADA ARZNEIMITTEL30,645+0,96 %Osram, Zinsen, Stada, Mifa, Facebook - unser Wochenrückblick
Die Börsen halten bis Dienstag ihren Osterschlaf, während die Autobranche mit großen Augen nach China schaut. Heute startet dort die Peking Auto-Show, und die Hersteller nutzen die Chance, sich dem...
--> Artikel lesen
VERTEX PHARMACEUTICALS48,781+0,77 %E-Commerce China Dangdang, Groupon, Microsoft, Vertex PharmaceuticalsandAlign Technology highlighted as Zacks Bull and Bear of the Day
CHICAGO, April 24, 2014 /PRNewswire/ --Zacks Equity Research highlights E-Commerce China Dangdang (NYSE:DANG-Free Report) as the Bull of the Day and Groupon (Nasdaq:GRPN-Free Report) as the Bear of...
--> Artikel lesen
Lade...